“We want to bring the drugs which are not available in India. The biggest factor is affordability. If you bring a medicine which is not affordable, there is no treatment,” said Chava, who is also the chief executive officer.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0MT1jJD
via IFTTT
0 comments:
Post a Comment